[HTML][HTML] Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer

…, Y Kinugasa, K Murofushi, TE Nakajima… - International journal of …, 2020 - Springer
The number of deaths from colorectal cancer in Japan continues to increase. Colorectal
cancer deaths exceeded 50,000 in 2016. In the 2019 edition, revision of all aspects of …

Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer

TE Nakajima, Y Yamada, T Hamano, K Furuta… - Cancer …, 2010 - Wiley Online Library
Adipocytokines are adipocyte‐secreted hormones associated with some malignancies such
as colorectal, breast, and prostate cancer. We hypothesized that changes in the levels of …

Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer

TE Nakajima, Y Yamada, T Hamano, K Furuta… - Journal of …, 2009 - Springer
Purpose Adipocytokines are adipocyte-secreted hormones associated with some malignancies.
We investigated the association of adipocytokines with gastric cancer. Methods The …

Phase I study of NK012, a novel SN-38–incorporating micellar nanoparticle, in adult patients with solid tumors

T Hamaguchi, T Doi, T Eguchi-Nakajima, K Kato… - Clinical Cancer …, 2010 - AACR
Purpose: We conducted a first-in-human phase I study to determine the dose-limiting toxicity
(DLT), evaluate the pharmacokinetic profile, and document any antitumor activity of NK012, …

[HTML][HTML] Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by …

…, Z Lu, BC Cho, IM Nor, M Ng, LT Chen, TE Nakajima… - Annals of …, 2019 - Elsevier
The most recent version of the European Society for Medical Oncology (ESMO) Clinical
Practice Guidelines for the diagnosis, treatment and follow-up of gastric cancer (GC) was …

Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer

…, N Mizuno, T Ioka, Y Omuro, TE Nakajima… - Cancer chemotherapy …, 2016 - Springer
Purpose Efficacy and safety of nab-paclitaxel plus gemcitabine have not been clarified in
Japanese patients with metastatic pancreatic cancer. No pharmacokinetic profile of co-…

[HTML][HTML] Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative …

…, WIW Zamaniah, WP Yong, KH Yeh, TE Nakajima… - Annals of …, 2019 - Elsevier
The most recent version of the European Society for Medical Oncology (ESMO) Clinical
Practice Guidelines for the diagnosis, treatment and follow-up of oesophageal cancer was …

Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II–III esophageal carcinoma

K Kato, T Eguchi Nakajima, Y Ito… - Japanese journal of …, 2013 - academic.oup.com
Objective Definitive chemoradiotherapy is one of the curative options for resectable
esophageal squamous cell carcinoma with organ preservation. We evaluated the efficacy and …

Multicenter phase I/II study of nivolumab combined with paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer

TE Nakajima, S Kadowaki, K Minashi, T Nishina… - Clinical Cancer …, 2021 - AACR
Purpose: We conducted a phase I/II study to investigate the safety and efficacy of nivolumab
with paclitaxel plus ramucirumab. Patients and Methods: Patients with advanced gastric …

Palliative radiation therapy for hemorrhage of unresectable gastric cancer: a single institute experience

…, H Mayahara, A Takashima, TE Nakajima… - Journal of cancer …, 2009 - Springer
Purpose To clarify the toxicity of palliative radiotherapy (RT) and its efficacy against bleeding
of unresectable gastric cancer. Methods Clinical data of 19 patients received palliative RT …